Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Revolution Medicines (RVMD) Receivables - Net (2020 - 2023)

Revolution Medicines (RVMD) has 4 years of Receivables - Net data on record, last reported at $1.3 million in Q4 2023.

  • For Q4 2023, Receivables - Net fell 73.16% year-over-year to $1.3 million; the TTM value through Dec 2023 reached $1.3 million, down 73.16%, while the annual FY2023 figure was $1.3 million, 73.16% down from the prior year.
  • Receivables - Net reached $1.3 million in Q4 2023 per RVMD's latest filing, up from $309000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $7.6 million in Q1 2021 and bottomed at $309000.0 in Q3 2023.
  • Average Receivables - Net over 4 years is $4.8 million, with a median of $5.4 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: decreased 7.26% in 2021, then crashed 93.74% in 2023.
  • A 4-year view of Receivables - Net shows it stood at $6.4 million in 2020, then fell by 7.26% to $5.9 million in 2021, then dropped by 21.18% to $4.7 million in 2022, then crashed by 73.16% to $1.3 million in 2023.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $1.3 million in Q4 2023, $309000.0 in Q3 2023, and $2.5 million in Q2 2023.